Item 8.01. Other Events.
On January 27, 2022, in light of ongoing developments impacting The Greenrose
Holding Company Inc. ("Greenrose" or the "Company") business projections,
Greenrose issued an updated presentation (the "Investor Presentation") included
as Exhibit 99.1 hereto and incorporated by reference into this Item 8.01.
Greenrose provides the Investor Presentation as an update to the Investor
Presentation filed by Greenrose on its Current Report on Form 8-K filed July 28,
2021 (the "July 28, 2021 Presentation").
The Investor Presentation filed herewith and the financial information and
projections reflected therein replace and supersede in all respects the July 28,
2021. The July 28, 2021 Presentation should no longer be relied upon by
investors, potential investors or other third parties.
The Investor Presentation includes financial information not prepared in
accordance with generally accepted accounting principles.
The information contained in the Investor Presentation is summary information
that is intended to be considered in the context of Greenrose's filings with the
Securities and Exchange Commission (the "Commission") and other public
announcements that Greenrose may make, by press release or otherwise, from time
to time. Greenrose undertakes no duty or obligation to publicly update or revise
the information contained in this report, although it may do so from time to
time as its management believes is warranted. Any such updating may be made
through the filing of other reports or documents with the Commission, through
press releases or through other public disclosure.
By filing this Current Report on Form 8-K and furnishing the information
contained herein, Greenrose makes no admission as to the materiality of any
information in this report that is required to be disclosed solely by reason of
Regulation FD.
Forward Looking Statements
Statements made in this Current Report on Form 8-K that are not historical facts
are "forward-looking statements" within the meaning of Section 21E of the
Securities Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. Forward-looking statements may relate to the
business combination and any other statements relating to future results,
strategy and plans of Greenrose (including certain projections and business
trends, and statements which may be identified by the use of the words "plans",
"expects" or "does not expect", "estimated", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases or state
that certain actions, events or results "may", "could", "would", "might",
"projects", "will" or "will be taken", "occur" or "be achieved"). Such
statements are provided for illustrative purposes only and are not to be relied
upon as predictions or any assurance or guarantee by any party of actual
performance of Greenrose and its recent acquisitions. Forward-looking statements
are based on the opinions and estimates of management of Greenrose and/or the
estimates of management of the companies Greenrose recently acquired, as the
case may be, as of the date such statements are made, and they are subject to
known and unknown risks, uncertainties, assumptions and other factors that may
cause the actual results, level of activity, performance or achievements to be
materially different from those expressed or implied by such forward-looking
statements. These risks and uncertainties include, but are not limited to, the
ability to attract and retain key personnel; prevailing industry trends
including consumer spending as well as in cannabis markets; legislation or
regulatory requirements and developments in the global economy in general and
the regulation of cannabis in particular; the public health crisis related to
the coronavirus (COVID-19) pandemic and resulting significant negative effects
to the global economy; disruption of global supply chains and distribution
channels; as well as significant volatility in and possible disruption of
financial markets; increased operating costs, decreased ability to profitably
develop and operate cultivation and processing facilities as well as retail
points of sale; competition in the US cannabis markets; and the impact of
government shutdowns or other limitations impacting business activity generally.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Investor Presentation
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
1
© Edgar Online, source Glimpses